LumiraDx Launches Rapid Onsite COVID-19 Surveillance Test
LumiraDx announced the U.S. launch of its COVID-19 Surveillance Test, for environments such as schools and workplaces.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Covid 19, POC Rapid Assays |
LumiraDx announced the U.S. launch of its COVID-19 Surveillance Test, for environments such as schools and workplaces.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Covid 19 |
Rapid saliva tests contributed to low COVID transmission among students, teachers, and staff in the the Special School District of St. Louis County.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Prostate |
During the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read MorePosted by Chris Wolski | Sep 1, 2021 | Cancer |
New diagnoses of eight common types of cancer significantly declined during most of the first 13 months of the pandemic.
Read MorePosted by Chris Wolski | Sep 1, 2021 | Covid 19 |
A study focused on multisystem inflammatory syndrome in children after infection with COVID found that half required ICU admission.
Read More